Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases

a technology of heterocyclic compounds and compounds, applied in the field of heterocyclic compounds, can solve the problems of increasing restrictions, limiting the use of antidiabetic treatment, and raising doubts about the intrinsic suitability of antidiabetic treatment, so as to reduce the toxic effect, no toxic effect, and enhance the effect of activity
USRE39266E1Inactive Publication Date: 2006-09-05DR REDDYS LAB LTD
89 Cites 41 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
DR REDDYS LAB LTD
Publication Date
2006-09-05
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a DIV of 09 / 353,286, filed on Jul. 14, 1999, now U.S. Pat. No. 6,114,526, which is a DIV of 08 / 884,816, filed Jun. 30, 1997, now U.S. Pat. No. 5,985,884 and a CIP of 08 / 772,627, filed Dec. 31, 1996, now U.S. Pat. No. 5,885,997.FIELD OF THE INVENTION

[0002] The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

[0003] The present invention also relates to a process for the preparation of the above said novel, azolidinedione derivatives, their tautomeric forms, their stereoisomers, their polymorphs, thei...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More